Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Lung Cancer

Free Subscription 22.04.2019 1 AJR Am J Roentgenol 1 Ann Oncol 2 BMC Cancer 1 Br J Cancer 1 Cancer Chemother Pharmacol 1 Cancer Res 1 Cancer Sci 1 Chest 4 Clin Cancer Res 1 Clin Nucl Med 1 Eur J Cancer 2 Int J Cancer 3 J Cancer Res Clin Oncol 1 J Clin Oncol 1 J Thorac Cardiovasc Surg 3 J Thorac Oncol 1 Lancet Respir Med 1 Mol Carcinog 2 Oncol Rep 2 Oncologist 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJR Am J Roentgenol

1. OTANI T, Hosono M, Kanagaki M, Onishi Y, et al
   Evaluation and Optimization of a New PET Reconstruction Algorithm, Bayesian Penalized Likelihood Reconstruction, for Lung Cancer Assessment According to Lesion Size.
   AJR Am J Roentgenol. 2019 Apr 17:1-7. doi: 10.2214/AJR.18.20478.
   PubMed     Text format     Abstract available
   
   

   
   Ann Oncol

2. SHAW AT, Riely GJ, Bang YJ, Kim DW, et al
   Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.
   Ann Oncol. 2019 Apr 13. pii: 5448502. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

3. VICKERS AD, Winfree KB, Cuyun Carter G, Kiiskinen U, et al
   Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis.
   BMC Cancer. 2019;19:353.
   PubMed     Text format     Abstract available
   
   
4. SIRIWARDHANA C, Khadka VS, Chen JJ, Deng Y, et al
   Development of a miRNA-seq based prognostic signature in lung adenocarcinoma.
   BMC Cancer. 2019;19:34.
   PubMed     Text format     Abstract available
   
   

   
   Br J Cancer

5. DEL RE M, Marconcini R, Pasquini G, Rofi E, et al
   PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC.
   Br J Cancer. 2018 Mar 6. pii: bjc20189. doi: 10.1038/bjc.2018.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Chemother Pharmacol

6. KATO Y, Okuma Y, Watanabe K, Yomota M, et al
   A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer.
   Cancer Chemother Pharmacol. 2019 Apr 16. pii: 10.1007/s00280-019-03843.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Res

7. KONDO Y
   Genome-Epigenome-Senescence: Is TET1 a Caretaker of p53-Injured Lung Cancer Cells?
   Cancer Res. 2019;79:1751-1752.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Sci

8. MASUDA N, Ohe Y, Gemma A, Kusumoto M, et al
   Safety and effectiveness of alectinib in a real-world surveillance study in patients with ALK-positive non-small-cell lung cancer in Japan.
   Cancer Sci. 2019;110:1401-1407.
   PubMed     Text format     Abstract available
   
   

   
   Chest

9. MACMAHON H, Li F, Jiang Y, Armato SG 3rd, et al
   Accuracy of the Vancouver Lung Cancer Risk Prediction Model Compared with Radiologists.
   Chest. 2019 Apr 11. pii: S0012-3692(19)30825-6. doi: 10.1016/j.chest.2019.
   PubMed     Text format     Abstract available
   
   

   
   Clin Cancer Res

10. YU H, Wu H, Wang W, Jolly S, et al
    Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non-Small-Cell Lung Cancer.
    Clin Cancer Res. 2019 Apr 16. pii: 1078-0432.CCR-18-1084.
    PubMed     Text format     Abstract available
    
    
11. KOH J, Kim HY, Lee Y, Park IK, et al
    IL-23-producing human lung cancer cells promote tumor growth via conversion of innate lymphoid cell 1 (ILC1) into ILC3.
    Clin Cancer Res. 2019 Apr 12. pii: 1078-0432.CCR-18-3458.
    PubMed     Text format     Abstract available
    
    
12. LEIGHL NB, Page RD, Raymond VM, Daniel DB, et al
    Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer.
    Clin Cancer Res. 2019 Apr 15. pii: 1078-0432.CCR-19-0624.
    PubMed     Text format     Abstract available
    
    
13. LUSK CM, Watza D, Dyson G, Craig DB, et al
    Profiling the mutational landscape in known driver genes and novel genes in African American non-small cell lung cancer patients.
    Clin Cancer Res. 2019 Apr 12. pii: 1078-0432.CCR-18-2439.
    PubMed     Text format     Abstract available
    
    

    
    Clin Nucl Med

14. SHEN G, Su M, Kuang A
    Primary Pulmonary Paraganglioma Revealed by FDG PET/CT.
    Clin Nucl Med. 2019 Jan 25. doi: 10.1097/RLU.0000000000002468.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cancer

15. MCGOWAN DR, Skwarski M, Bradley KM, Campo L, et al
    Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma.
    Eur J Cancer. 2019;113:87-95.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

16. CHRISTOPOULOS P, Kirchner M, Bozorgmehr F, Endris V, et al
    Identification of a highly lethal V3(+) TP53(+) subset in ALK(+) lung adenocarcinoma.
    Int J Cancer. 2019;144:190-199.
    PubMed     Text format     Abstract available
    
    
17. WANG R, Peng S, Zhang X, Wu Z, et al
    Inhibition of NF-kappaB improves sensitivity to irradiation and EGFR-TKIs and decreases irradiation-induced lung toxicity.
    Int J Cancer. 2019;144:200-209.
    PubMed     Text format     Abstract available
    
    

    
    J Cancer Res Clin Oncol

18. MELLING N, Bachmann K, Hofmann B, El Gammal AT, et al
    Prevalence and clinical significance of RBM3 immunostaining in non-small cell lung cancers.
    J Cancer Res Clin Oncol. 2019;145:873-879.
    PubMed     Text format     Abstract available
    
    
19. CHENG X, Yin H, Fu J, Chen C, et al
    Aggregate analysis based on TCGA: TTN missense mutation correlates with favorable prognosis in lung squamous cell carcinoma.
    J Cancer Res Clin Oncol. 2019;145:1027-1035.
    PubMed     Text format     Abstract available
    
    
20. WANG L, Liu J, Liu J, Chen X, et al
    GLRX inhibition enhances the effects of geftinib in EGFR-TKI-resistant NSCLC cells through FoxM1 signaling pathway.
    J Cancer Res Clin Oncol. 2019;145:861-872.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

21. PASSARO A, Spitaleri G, Gyawali B, de Marinis F, et al
    Immunotherapy in Non-Small-Cell Lung Cancer Patients With Performance Status 2: Clinical Decision Making With Scant Evidence.
    J Clin Oncol. 2019 Apr 17:JCO1802118. doi: 10.1200/JCO.18.02118.
    PubMed     Text format    
    
    

    
    J Thorac Cardiovasc Surg

22. GRAVIER FE, Bonnevie T, Boujibar F, Medrinal C, et al
    Effect of prehabilitation on ventilatory efficiency in non-small cell lung cancer patients: A cohort study.
    J Thorac Cardiovasc Surg. 2019 Feb 19. pii: S0022-5223(19)30448.
    PubMed     Text format     Abstract available
    
    

    
    J Thorac Oncol

23. REMON J, Ahn MJ, Girard N, Johnson M, et al
    Advanced Stage Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018.
    J Thorac Oncol. 2019 Apr 16. pii: S1556-0864(19)30280.
    PubMed     Text format     Abstract available
    
    
24. SORICH MJ, Rowland A, Karapetis CS, Hopkins AM, et al
    Evaluation of the lung immune prognostic index for prediction of survival and response in patients treated with atezolizumab for non-small cell lung cancer: pooled analysis of clinical trials.
    J Thorac Oncol. 2019 Apr 15. pii: S1556-0864(19)30285.
    PubMed     Text format     Abstract available
    
    
25. MANOHARAN P, Salem A, Mistry H, Gornall M, et al
    [18F]fludeoxyglucose PET/CT in small-cell lung cancer: Analysis of the CONVERT randomized controlled trial.
    J Thorac Oncol. 2019 Apr 16. pii: S1556-0864(19)30282.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Respir Med

26. ZHOU C, Kim SW, Reungwetwattana T, Zhou J, et al
    Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study.
    Lancet Respir Med. 2019 Apr 10. pii: S2213-2600(19)30053.
    PubMed     Text format     Abstract available
    
    

    
    Mol Carcinog

27. GUO Y, Feng Y, Liu H, Luo S, et al
    Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
    Mol Carcinog. 2019 Apr 15. doi: 10.1002/mc.23017.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

28. XU C, Wu P, Gao J, Zhang L, et al
    Heptadecanoic acid inhibits cell proliferation in PC9 nonsmallcell lung cancer cells with acquired gefitinib resistance.
    Oncol Rep. 2019 Apr 18. doi: 10.3892/or.2019.7130.
    PubMed     Text format     Abstract available
    
    
29. MU X, Li H, Zhou L, Xu W, et al
    TRIM52 regulates the proliferation and invasiveness of lung cancer cells via the Wnt/betacatenin pathway.
    Oncol Rep. 2019 Apr 11. doi: 10.3892/or.2019.7110.
    PubMed     Text format     Abstract available
    
    

    
    Oncologist

30. ZHANG C, Sun X, Dang K, Li K, et al
    Toward an Expert Level of Lung Cancer Detection and Classification Using a Deep Convolutional Neural Network.
    Oncologist. 2019 Apr 17. pii: theoncologist.2018-0908.
    PubMed     Text format     Abstract available
    
    
31. CRINO L, Bidoli P, Delmonte A, Grossi F, et al
    Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population.
    Oncologist. 2019 Apr 17. pii: theoncologist.2018-0737.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

32. SHIRASAWA M, Fukui T, Kusuhara S, Harada S, et al
    Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.
    PLoS One. 2019;14:e0214599.
    PubMed     Text format     Abstract available
    
    
33. DUNCAN DJ, Scott M, Scorer P, Barker C, et al
    Assessment of PD-L1 mRNA and protein expression in non-small cell lung cancer, head and neck squamous cell carcinoma and urothelial carcinoma tissue specimens using RNAScope and immunohistochemistry.
    PLoS One. 2019;14:e0215393.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

34. VILLANOVA T, Gesmundo I, Audrito V, Vitale N, et al
    Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.
    Proc Natl Acad Sci U S A. 2019;116:2226-2231.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: